Issue Number 47             January 20, 1999


  1. 20/20 will air hepatitis B vaccine news story on Friday


Back to Top

January 22, 1999

The ABC 20/20 news story on hepatitis B vaccine that was postponed last week is now rescheduled to air on Friday, January 22, at 10 p.m., EST. According to the Centers for Disease Control and Prevention (CDC), the program is likely to focus on alleged adverse events associated with hepatitis B vaccine.

Any member of the media who contacts you and wishes to speak with
a CDC expert regarding this broadcast should be referred to CDC's Media Relations Division (404-639-3286). The Media Relations
Division can direct reporters to CDC's hepatitis B vaccine and vaccine safety experts. You may also want to refer members of the media to the website links listed below or consider forwarding them this e-mail.

CDC is also very interested in how many calls you or your organization receive as a result of this national news story as well as the nature of those inquiries. This information will help CDC better serve you and your patients/clients. E-mail this information to Glen Nowak, Associate Director for Communications at the National Immunization Program, at or click here:

The following information on the 20/20 broadcast was sent to IAC EXPRESS subscribers on January 11. It includes information about where to obtain reliable information on the safety and efficacy of hepatitis B vaccine.

In a letter dated January 8, Walter A. Orenstein, M.D., M.P.H., Assistant Surgeon General, Director, National Immunization Program, CDC, wrote the following:

"From interview questions, we surmise that 20/20's story is likely to focus on alleged adverse events associated with hepatitis B vaccine (e.g., multiple sclerosis, chronic fatigue syndrome, optic neuritis, Lupus). We also know that the 20/20 reporters contacted states to learn more about laws requiring hepatitis B vaccination."

To assist health professionals in responding to questions generated by the story, CDC released a message from Dr. Orenstein. The message appears on CDC's website and is dated January 8. It reads as follows:

"Infant, adolescent, and adult immunization plays an important role in disease prevention and reduction. Although no vaccine is perfect, the benefits of immunization far outweigh the risks. Thanks to vaccines, fewer cases of vaccine-preventable diseases were reported in 1998 than in any previous year. In addition, recent changes in the nation's vaccine recommendations have made immunizations even safer.

"The National Immunization Program is committed to strengthening vaccine programs and further improving disease prevention. Vaccine safety is constantly monitored and vaccine safety concerns are being investigated and addressed.

"Today, thanks to their relative rarity, it is easy to forget that vaccine-preventable diseases can cause lasting brain damage, liver cancer, paralysis, and premature death. It is important to remember, however, vaccines are the primary reason there are so few cases of such childhood diseases as measles, whooping cough, rubella (German measles), and hepatitis B."

CDC has also included a list of links on their website that will provide you with more information about hepatitis B vaccine. You can click on any of the following items or you can click here and receive the list of links as well as the above message.

1. General information on hepatitis B vaccine,

2. Questions and answers on hepatitis B vaccine,

3. Questions and answers on vaccine safety,

4. Vaccine safety and injury compensation,

5. "What Would Happen If We Stopped Vaccination?"

6. A recent statement on the importance of immunization by Donna Shalala, Secretary, U.S. Department of Health and Human  Services,

7. A list of contact telephone numbers and Internet sites that can be accessed to provide more information.

Current information on hepatitis and the hepatitis B vaccine can also be obtained by contacting:
National Immunization Information Hotline (1-800-232-2522) Hepatitis Hotline (1-888-443-7232)
National Immunization Program website at
Hepatitis Branch website at

About IZ Express

IZ Express is supported in part by Grant No. 1NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of and do not necessarily represent the official views of CDC.

IZ Express Disclaimer
ISSN 2771-8085

Editorial Information

  • Editor-in-Chief
    Kelly L. Moore, MD, MPH
  • Managing Editor
    John D. Grabenstein, RPh, PhD
  • Associate Editor
    Sharon G. Humiston, MD, MPH
  • Writer/Publication Coordinator
    Taryn Chapman, MS
    Courtnay Londo, MA
  • Style and Copy Editor
    Marian Deegan, JD
  • Web Edition Managers
    Arkady Shakhnovich
    Jermaine Royes
  • Contributing Writer
    Laurel H. Wood, MPA
  • Technical Reviewer
    Kayla Ohlde

This page was updated on .